Genetic Tools Europe B.V.

About Genetic Tools Europe B.V.

Genetic Tools Europe B.V. is a biotechnology company pioneering next-generation molecular diagnostics. In collaboration with the Netherlands Cancer Institute (Antoni van Leeuwenhoek, NKI), we have developed a breakthrough test method that makes it possible to detect cancer in its ultra-early stages even before symptoms arise.

Our proprietary technology is estimated to be one million times more sensitive than current PCR-based diagnostics. It can detect 1 in 1 billion cells, without generating false positives. Results are delivered in under two hours, using standard lab infrastructure making worldwide implementation fast, cost-effective, and accessible.

This innovation is based on a newly discovered dual-action enzyme, the result of over 20 years of scientific research. It enables early detection that may shift cancer from a deadly disease to a manageable condition.

Headquartered in Rosmalen, Genetic Tools Europe is committed to translating deep scientific insight into practical tools that empower early intervention, more effective treatment, and better outcomes for patients worldwide.

We are currently expanding partnerships with hospitals, research institutes, and diagnostic labs to bring this technology into clinical use.

Address

• Headquarters

  Tuinstraat 85241AA RosmalenNoord-Brabant, Netherlands

Team by function

Based on 1 public job profiles as of 4 September 2026.

• Engineering / Software Development1